News | Radiation Therapy | July 21, 2023

Multiple oral presentations evaluate potential of SCINTIX biology-guided radiotherapy, including accuracy of multi-target delivery 

Multiple oral presentations evaluate potential of SCINTIX biology-guided radiotherapy, including accuracy of multi-target delivery

SCINTIX therapy, delivered by the RefleXion X1, uses emissions from cancer cells created by injecting the patient with a radiopharmaceutical to deliver a radiation dose that continuously and autonomously targets the cancer itself. (Photo: Business Wire) 
 


July 21, 2023 — RefleXion Medical, a therapeutic oncology company, today announced that researchers from multiple clinical programs will present new scientific evidence in 28 oral, panel, and poster presentations validating the efficacy and feasibility of the RefleXion X1 machine with SCINTIX biology-guided radiotherapy at the 2023 American Association of Physicists in Medicine (AAPM) Annual Meeting in Houston, July 23-26. The company will also hold multi-target SCINTIX technology interactive demonstrations in booth #501. 

“As we are on the cusp of treating patients with SCINTIX therapy, we’re extremely gratified to have this significant scientific presence that includes five oral and panel presentations, and a poster designated as a blue-ribbon recipient,” said Sean Shirvani, M.D., chief medical officer of RefleXion. “Several of these presentations detail our successfully completed clinical study that supported our FDA clearance for SCINTIX therapy, while others explore its breakthrough potential in treating multiple moving tumors.” 

The following oral and panel presentations highlight some of the new research about the accuracy of multi-target SCINTIX therapy, as well as the high degree of accuracy in achieving the primary endpoint from BIOGUIDE-X, the first-in-human clinical study for SCINTIX therapy. Detailed information on all 28 presentations may be found here

Oral Presentations and Panels: 

  • Oral: Assessment of the Accuracy of Multi-Target Biology-guided RadiotherapyDelivery, Murat Surucu, Ph.D.
    Sunday, July 23, 2:21 pm, Room 362 
  • Panel: Biology-Guided Adaptive Radiotherapy, Nataliya Kovalchuk, Ph.D.
    Monday, July 24, 4:35 pm, Room 372 
  • Oral: Patient Specific Quality Assurance Verification of Biology-guided Radiotherapy Plans from the First-in-Human Clinical Trial, Bin Cai, Ph.D
    Tuesday, July 25, 10:45 am, Room 372 
  • Oral: Demonstration of in-Silico Biology-Guided Radiotherapy Delivery Using Data Acquired on the First Installation of O-Ring Gantry PET/CT Radiotherapy System, Manoj Narayanan, Ph.D.
    Tuesday, July 25, 10:55 am, Room 372 
  • Panel: Adaptive RT on the RefleXion Platform, Murat Surucu, Ph.D.
    Wednesday, July 26, 9:15 am, Room 362 

 

RefleXion is also hosting an industry lunch symposium during the AAPM annual meeting at 12:30 PM CDT on July 24. Physicists Murat Surucu, Ph.D., Chunhui Han, Ph.D., and Bin Cai, Ph.D., will share their clinical experience with the X1 and how they are preparing for SCINTIX therapy. 

Overcoming the hurdles of targeting and motion management, especially for multiple tumors, is the core challenge in external-beam radiotherapy. SCINTIX therapy, delivered by the RefleXion X1, uses emissions from cancer cells created by injecting the patient with a radiopharmaceutical to deliver a radiation dose that continuously and autonomously targets the cancer itself. Moreover, this fundamental capability simultaneously lights up all targeted tumors in the body during treatment. SCINTIX technology handles tumor motion from all types of movement, including expected motion from internal processes such as breathing and digestion or unexpected movement by a patient. 

For more information: www.reflexion.com 

Find more AAPM23 conference coverage here


Related Content

News | Artificial Intelligence

November 28, 2023 — iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, and ...

Time November 28, 2023
arrow
News | Treatment Planning

November 26, 2023 — TeleDaaS, PLLC, a leading dosimetry-as-a-service provider, made its official debut today at the ...

Time November 26, 2023
arrow
News | Breast Imaging

November 21, 2023 —iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, and CancerIQ ...

Time November 21, 2023
arrow
News | Breast Imaging

November 20, 2023 — The American Society for Radiation Oncology (ASTRO) issued a clinical guideline on partial breast ...

Time November 20, 2023
arrow
News | Artificial Intelligence

November 15, 2023 — The 2023 Radiological Society of North America (RSNA) Alexander R. Margulis Award for Scientific ...

Time November 15, 2023
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

As another month comes to a close, ITN takes a look at the Top 10 most-read pieces of content from www.itnonline.com ...

Time November 06, 2023
arrow
News | ASTRO

November 3, 2023 —The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time November 03, 2023
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

Imaging advancements, including 3D Doppler imaging to detect cancers in numerous organs, are used to accurately guide ...

Time November 03, 2023
arrow
Feature | Radiation Oncology | By Christine Book

Howard Sandler, MD, FASTRO, Radiation Oncology Department Chair at Cedars-Sinai Medical Center, took the helm as ...

Time November 03, 2023
arrow
News | Artificial Intelligence

November 2, 2023 — GE HealthCare’s Artificial Intelligence (AI) models predict patient response to immunotherapies with ...

Time November 02, 2023
arrow
Subscribe Now